April 26 (Reuters) - CSPC Pharmaceutical Group Ltd
:
* QTRLY NET PROFIT ATTRIBUTABLE OF CSPC INNOVATION PHARMACEUTICAL RMB77.7 MILLION VERSUS RMB63.7 MILLION
* QTRLY REVENUE OF CSPC INNOVATION PHARMACEUTICAL RMB357.1 MILLION VERSUS RMB355.6 MILLION
Source text for Eikon: Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
精彩评论